OVERVIEW
The demand for medical simulation is expected to hit USD 2,856.4 million by 2024, increasing over the forecast period at a CAGR of 14.45%. The benefits of simulation over traditional learning, increased demand for minimally invasive treatments, and increased focus on patient safety are the key factors driving the growth of the market’s significant growth drivers.
TABLE OF CONTENT
1 Global Healthcare / Medical Simulation Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Healthcare / Medical Simulation Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Healthcare / Medical Simulation Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Healthcare / Medical Simulation Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Healthcare / Medical Simulation Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.1.1 Advantage of simulation over traditional learning
6.2.1.2 Rising demand for minimally invasive treatments
6.2.1.3 Increasing focus on patient safety
6.2.2 Challenges
6.2.2.1 High cost of simulators
6.2.2.2 Operational challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Healthcare / Medical Simulation Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Healthcare / Medical Simulation Market – By Product & Service (Market Size – &million/billion)
8.1 Anatomical Models
8.2 Web-Based Simulation
8.3 Medical Simulation Software
8.4 Simulation Training Services
9 Global Healthcare / Medical Simulation Market – By End-User
9.1 Academic Institutes
9.2 Hospitals
9.3 Military Organizations
9.4 Other
10 Global Healthcare / Medical Simulation Market – By Geography (Market Size – &million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa
11 Global Healthcare / Medical Simulation Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships
12 Global Healthcare / Medical Simulation Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 CAE Inc.
12.3 Laerdal Medical
12.4 3D Systems
12.5 Gaumard Scientific Company
12.6 Limbs & Things
12.7 Medaphor
12.8 Mentice
12.9 Simulaids
12.10 Kyoto Kagaku
12.11 Simulab
12.12 Company 11 & more
13 Global Healthcare / Medical Simulation Market – Appendix
13.1 Sources
13.2 Abbreviations